Table 3.
Association of PTSD symptoms with FoH, and depressive symptoms by using generalized linear models (n = 242)
| FoH (CHFSII-WS) | Depressive symptoms (PHQ-9) | |||
|---|---|---|---|---|
| β (95% CI) | P value | β (95% CI) | P value | |
| Model 1 | 0.0132(0.0025,0.0239) | 0.016 | 0.0172(0.0100,0.0245) | < 0.0001 |
| Model 2 | 0.0161(0.0041,0.0280) | 0.009 | 0.0162(0.0090,0.0233) | < 0.0001 |
| Model 3 | 0.0171(0.0055,0.0287) | 0.004 | 0.0148(0.0076,0.0220) | < 0.0001 |
Model 1: unadjusted
Model 2: adjusted for age (continuous), gender, marital status, educational attainment, residential area, and diabetes treatment affordability
Model 3: further adjusted for diabetes duration(continuous), glucose-lowering medication types, history of hypoglycemia, history of COVID-19, and the number of diabetes-related comorbidities (continuous)
PTSD Post-traumatic stress disorder, FoH Fear of hypoglycemia, CHFSII-WS Chinese version of Hypoglycemia Fear Survey II-Worry Scale, PHQ-9 Patient health questionnaire-9, CI Confidence interval